Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.

Carl Walkey
SVP of Corporate Development
Daniel-Adriano Silva
Vice President of Research
Kamran Alam
Senior Strategic Advisor
Robert Ho
Samantha Willing
Vice President, People
Umut Ulge
VP of Translational Medicine
Priti Patel
Chief Medical Officer
Holly K. Vance
General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.